查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1718109

血液学检测市场按产品类型、检测类型、样本类型、应用和最终用户划分－2025-2030 年全球预测

Blood Testing Market by Products, Test Type, Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计血液检测市场规模将从 2024 年的 1,056.6 亿美元成长至 2025 年的 1,148.7 亿美元，复合年增长率为 8.87%，到 2030 年将达到 1,760.3 亿美元。

主要市场统计数据
基准年2024年 1056.6亿美元
预计2025年 1148.7亿美元
预测年份 2030 1760.3亿美元
复合年增长率（%） 8.87%

血液检测已成为现代医学的基石，持续支持准确的诊断、治疗计划和健康监测。在技​​术创新和不断变化的临床需求相交的市场中，本报告深入探讨了重新定义血液学检测领域的当前趋势、机会和挑战。近年来，生化方法、数位资料整合和简化的样本处理的进步为提高准确性、效率和以患者为中心的护理铺平了道路。

本报告全面介绍了技术突破与对市场动态的深入了解如何改变常规业务。分析采用定量和定性研究，为决策者提供可行的见解，弥合新兴创新与实际应用之间的差距。它还深入研究市场区隔、区域趋势和竞争动态，以揭示推动成长的相互关联的因素。

随着医疗保健的不断发展，了解血液检测领域的复杂发展比以往任何时候都更加重要。此次标准的通过为深入讨论奠定了基础，不仅将重点关注测试方法的不断创新和改进，而且还强调了相关人员寻求在这一快速发展的领域保持领先地位所必需的战略必要事项。

重新定义血液检测格局的变革

近年来，革命性的变化正在发生，大大改变了血液检测环境。透过自动化、数据分析和先进感测器技术的整合，检测设备不仅更加准确，而且更适合满足快速诊断的需求。同时，数位数位资料管理和软体解决方案的进步使得将测试结果无缝整合到更广泛的患者健康记录中成为可能，从而提高了决策的速度和准确性。

许多进步都是由全球对精准医疗日益增长的关注所推动的。因此，测试设备变得越来越灵活，可以缩短週转时间并减少手动流程中典型的操作限制。法律规范也在不断发展，以鼓励创新，同时保持高标准的临床相关性和病人安全。

本节重点介绍技术与医疗保健服务之间的动态交互作用，解释改进的自动化、更高的数据互通性和新颖的设备设计如何融合以提升血液学检测领域的整体患者照护标准。这些发展预示着该行业拥有强劲的未来，其特点是效率提高、市场竞争加剧以及具有突破性研发和临床应用的潜力。

全面的市场区隔与深入的分析

血液检测市场呈现丰富的细分市场，可以更了解消费者需求和技术进步。按产品进行详细分析，可以发现其结构涵盖采血用品、先进的血液学检测设备、必需试剂和消耗品、资料管理解决方案和整合软体。值得注意的是，血液采集部分进一步细分为不同的类别，例如采集管、毛细血管采血装置、采血针以及经常被忽视的注射器和针头。同样，血液学检测设备部分分为各种基本仪器，包括生化分析仪、凝血分析仪、血液学分析仪和免疫检测分析仪。

除了产品类型外，市场还根据测试类型进行细分，例如代谢组、全血球计数测试、完整代谢组、电解质组等。这种分类允许相关人员根据应用评估诊断的有效性和效能。此外，按检体类型划分，透过区分动脉血液检体、毛细血管检体、血浆或血清检体和静脉血液检体，可以更细緻地了解这个过程。

当您考虑到推动市场需求的多样化应用时，其深度就更大了。按应用进行的专业细分突出了过敏诊断、自体免疫疾病、癌症和非癌症血液疾病、内分泌系统疾病和心臟疾病的活动。最后，针对血库、诊断中心、医院诊所和病理实验室等主要市场管道的最终用户细分也很重要。每个部分都提供了对使用者特定需求的关键见解，从而能够在日益复杂的医疗保健环境中采用客製化的产品和服务开发方法。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球对早期诊断和预防医学的需求日益增长
      • 基因组学和生物标记血液分析支持的个人化医疗日益普及
      • 就地检验设施的快速扩张增加了即时诊断结果的机会
    • 限制因素
      • 先进血液学检测设备生产与营运成本高昂
    • 机会
      • 人工智慧和机器学习在先进血液检测技术中的融合
      • 投资研发技术创新
    • 任务
      • 伦理问题和病人机密资讯的潜在滥用
  • 市场区隔分析
    • 测试类型：对评估电解质失衡和肾功能的代谢面板的需求不断增长
    • 最终用户：血库越来越多地使用血液检测技术来确保输血安全
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章血液检测市场（按产品）

  • 介绍
  • 血液收集
    • 采血管（BCT）
    • 微血管采血装置
    • 《采血针》
    • 注射器和针头
  • 血液检测设备
    • 生化分析仪
    • 凝血分析仪
    • 血液分析仪
    • 免疫检测分析仪
  • 试剂和耗材
  • 软体和数据管理解决方案

第七章 血液检测市场（依检测类型）

  • 介绍
  • 基础代谢率面板
  • 全血球计数
  • 完整代谢组
  • 电解质面板

第八章 血液检测市场（依样本型）

  • 介绍
  • 动脉血样本
  • 微血管血液样本
  • 血浆/血清样本
  • 静脉血液样本

第九章 血液检测市场（依应用）

  • 介绍
  • 过敏
  • 自体免疫疾病
  • 癌症/非癌症血液疾病
  • 内分泌失调
  • 心臟病

第 10 章 血液检测市场（依最终用户划分）

  • 介绍
  • 血库
  • 诊断中心
  • 医院和诊所
  • 病理实验室

第 11 章：美洲血液检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血液检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲血液检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • A. Menarini Diagnostics srl
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson & Company
  • Bio-Rad Laboratories Inc.
  • BioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Ortho Clinical Diagnostics, Inc.
  • Quest Diagnostic
  • Randox Laboratories Ltd.
  • Siemens AG
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Trinity BIoTech PLC
  • Trividia Health, Inc.
  • Ypsomed AG
Product Code: MRR-144C638C91DF

The Blood Testing Market was valued at USD 105.66 billion in 2024 and is projected to grow to USD 114.87 billion in 2025, with a CAGR of 8.87%, reaching USD 176.03 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 105.66 billion
Estimated Year [2025] USD 114.87 billion
Forecast Year [2030] USD 176.03 billion
CAGR (%) 8.87%

Blood testing has emerged as a cornerstone of modern healthcare, consistently supporting accurate diagnosis, treatment planning, and health monitoring. In a market where technological innovation and evolving clinical demands intersect, this report provides a meticulous exploration of current trends, opportunities, and challenges redefining the blood testing landscape. Over recent years, advances in biochemical methodologies, digital data integration, and streamlined sample processing have created a milieu of enhanced accuracy, efficiency, and patient-centric care.

This report offers a comprehensive look at how traditional practices have been transformed through a combination of technological breakthroughs and a deeper understanding of market dynamics. The analysis is grounded in both quantitative and qualitative research, providing decision-makers with actionable insights that bridge the gap between emerging innovations and practical applications. Throughout, the content delves into market segmentation, regional trends, and competitive dynamics, elucidating the interconnected factors driving growth.

As healthcare continues to evolve, staying informed about the intricate developments within the blood testing segment is more critical than ever. This introduction sets the stage for a detailed discussion that not only highlights the continuous innovations and refinements in testing methodologies but also emphasizes the strategic imperatives necessary for stakeholders aiming to remain at the forefront of this rapidly advancing field.

Transformative Shifts Redefining Blood Testing Landscape

Recent years have witnessed transformative shifts that are reshaping the blood testing environment in profound ways. The integration of automation, data analytics, and advanced sensor technologies has resulted in testing instruments that are not only more precise but also better suited to meet the demands of rapid diagnostic contexts. In parallel, the evolution of digital data management and software solutions now allows for seamless integration of testing results into broader patient health records, bolstering both decision-making speed and accuracy.

Many of these advancements have been driven by a global emphasis on precision medicine, where targeted treatments require granular, accurate patient datasets. As such, testing instruments are becoming increasingly agile, facilitating faster turnaround times and reducing the operational constraints typically associated with manual processes. Regulatory frameworks are also evolving, encouraging innovation while maintaining high standards of clinical validity and patient safety.

This section underscores the dynamic interplay between technology and healthcare delivery, illustrating how improved automation, enhanced data interoperability, and novel instrument designs are converging to elevate the overall standard of patient care within the blood testing sector. These developments signal a robust future for the industry, characterized by increased efficiency, heightened market competitiveness, and the potential for groundbreaking research and clinical applications.

Comprehensive Market Segmentation and Detailed Analysis

The blood testing market exhibits a rich tapestry of segmentation that enhances the understanding of both consumer needs and technological advancements. A detailed analysis based on products reveals a structure that encompasses blood collection supplies, sophisticated blood testing instruments, essential reagents and consumables, and integrated software alongside data management solutions. In particular, the blood collection segment is dissected further into distinct categories such as blood collection tubes, capillary blood collection devices, lancets, and the often-overlooked syringes and needles. Similarly, the realm of blood testing instruments is broken down into various essential devices including biochemical analyzers, coagulation analyzers, hematology analyzers, and immunoassay analyzers.

Beyond product classification, the market is also segmented according to test type where distinctions are made among basic metabolic panels, complete blood count tests, complete metabolic panels, and electrolyte panels. This division allows stakeholders to evaluate diagnostic efficacy and application-specific performance. Moreover, segmentation by sample type offers a nuanced view of the process, differentiating among arterial blood samples, capillary blood samples, plasma or serum samples, and venous blood samples.

Further depth is added when considering the varied applications driving market demand. Specialized segmentation based on application sheds light on activities across allergy diagnostics, autoimmune diseases, cancer and noncancerous blood disorders, endocrine system disorders, and heart diseases. Finally, an important consideration is the end-user segmentation, which addresses key market outlets including blood banks, diagnostic centers, hospitals and clinics, and pathology labs. Each of these segmentation categories offers critical insight into user-specific needs, enabling a tailored approach to product and service development in an increasingly complex healthcare environment.

Based on Products, market is studied across Blood Collection, Blood Testing Instruments, Reagents & Consumables, and Software & Data Management Solutions. The Blood Collection is further studied across Blood Collection Tubes (BCTs), Capillary Blood Collection Devices, Lancets, and Syringes & Needles. The Blood Testing Instruments is further studied across Biochemical Analyzers, Coagulation Analyzers, Hematology Analyzers, and Immunoassay Analyzers.

Based on Test Type, market is studied across Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels, and Electrolyte Panels.

Based on Sample Type, market is studied across Arterial Blood Samples, Capillary Blood Samples, Plasma/Serum Samples, and Venous Blood Samples.

Based on Application, market is studied across Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders, Endocrine System Disorders, and Heart Diseases.

Based on End-User, market is studied across Blood Banks, Diagnostic Centers, Hospital & Clinics, and Pathology Labs.

Regional Landscape: Shifting Dynamics Across Global Markets

The global blood testing market is markedly influenced by regional dynamics, which profoundly affect market behavior and growth prospects. In the Americas, robust healthcare infrastructure and escalating demand for advanced diagnostic procedures drive innovation and consistent market expansion. This region has rapidly embraced modern technology, leading to improvements in diagnostic protocols and a growing emphasis on preventive care.

Across Europe, the Middle East, and Africa, the market is shaped by a blend of mature healthcare systems and emerging markets that are rapidly investing in modern diagnostic capabilities. These regions are witnessing an increase in public-private partnerships and research initiatives aimed at elevating healthcare outcomes. Stakeholders in these markets are increasingly leveraging advanced blood testing technologies to manage chronic diseases, thereby ensuring higher levels of reliability and timeliness in patient care.

In the Asia-Pacific region, rapid economic development, coupled with increased investment in healthcare infrastructure, has resulted in a burgeoning demand for state-of-the-art diagnostic tools. The region's emphasis on scalability and efficiency has spurred innovations within both public health institutions and private healthcare providers. Collectively, these geographical insights underscore the importance of adapting strategies to the unique economic, regulatory, and technological landscapes present in different regions, each contributing unique strengths and challenges to the overarching global blood testing narrative.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders and Competitive Dynamics in Blood Testing

In an industry driven by technological advancements and relentless innovation, market leadership is defined by the ability to integrate cutting-edge research with pragmatic clinical applications. Prominent companies have distinguished themselves by deploying advanced diagnostic instruments and comprehensive data management systems that set new standards in precision and operational efficiency. Notable players have not only refined their product portfolios but have also embraced strategic partnerships that drive innovation. Among the market leaders, companies such as A. Menarini Diagnostics s.r.l. and Abbott Laboratories have consistently delivered robust solutions, while ACON Laboratories, Inc. and ARKRAY, Inc. expand their market presence with innovative diagnostic tools.

Other influential organizations, including B. Braun Melsungen AG and Becton Dickinson & Company, have made significant investments to ensure that their blood testing instruments remain at the forefront of technological advancement. Leaders in this sector such as Bio-Rad Laboratories Inc. and BioMerieux SA have leveraged their extensive research and development capabilities to introduce solutions that address both emerging health challenges and routine diagnostic needs. Crowned with further endorsements, Danaher Corporation and F. Hoffmann-La Roche AG have been instrumental in shaping industry standards through continual enhancements and strategic market positioning.

The competitive landscape is further enriched by the progressive contributions of Johnson & Johnson Services, Inc., Medtronic PLC, and Merck KGaA, who continue to prioritize innovation and reliability. Additional key companies such as Nipro Corporation, Nova Biomedical Corporation, Ortho Clinical Diagnostics, Inc., Quest Diagnostic, and Randox Laboratories Ltd. have carved out significant niches. The leadership of Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG further accentuates a market characterized by competitive rigor and rapid technological progression. Their diverse approaches and comprehensive portfolios provide a testament to a dynamic market where innovation, strategic investments, and global outreach combine to create lasting value for stakeholders.

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., BioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Ortho Clinical Diagnostics, Inc., Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG. Strategic and Actionable Recommendations for Industry Leaders

For industry leaders aiming to capitalize on evolving market trends, a set of strategic recommendations can serve as a roadmap for sustained competitive advantage. It is essential to prioritize technology integration, ensuring that advanced diagnostic instruments and data management systems are seamlessly incorporated into existing clinical workflows. Leaders should invest in research and development initiatives that focus on enhancing the precision and speed of blood testing processes while simultaneously reducing overall costs.

A key strategy involves fostering strong collaborative relationships across the supply chain. By integrating input from product developers, healthcare practitioners, and regulatory bodies, companies can accelerate the innovation cycle while ensuring that new products are both clinically relevant and market-ready. Additionally, embracing digital transformation through the adoption of artificial intelligence and machine learning technologies can significantly enhance data interpretation and operational decision-making, yielding improved patient outcomes.

Operational efficiency should also be a central pillar of any forward-looking strategy. This involves upgrading existing instrumentation and refining the processes associated with sample collection and testing. It is critical to optimize resource allocation by leveraging recent advancements in automation and remote diagnostics. Furthermore, expanding market footprint through targeted regional initiatives can help companies tap into emerging markets, particularly in regions where healthcare infrastructure is rapidly advancing.

In light of the competitive dynamics and competitive pressures in the market, it is crucial for leaders to maintain agility. By continually monitoring market trends and adopting proactive adjustments to their business models, industry players can ensure they remain at the leading edge of diagnostic innovation. This approach not only drives profitability but also enhances the capacity to deliver superior clinical care in the face of ever-evolving patient care demands.

Conclusion: Insights and Future Outlook

The blood testing market is clearly defined by its rapid evolution, technological advancements, and the unwavering demand for improved diagnostic precision. Concluding this exploration, the report brings together an analysis of transformative shifts, detailed market segmentation, regional dynamics, and competitive positioning among industry leaders. The insights reflect how innovation and strategic investments in research and development are reshaping clinical practices and enabling more accurate, efficient, and patient-centered care.

Ultimately, the convergence of advanced testing methodologies and digital integration paves the way for unprecedented growth opportunities. The interplay of market drivers underscores the importance of staying ahead of technological trends and regulatory changes. As the industry continues to mature, stakeholders who remain agile and strategically focused are well-positioned to benefit from emerging opportunities that redefine healthcare delivery and outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for early diagnosis and preventive healthcare practices worldwide
      • 5.1.1.2. Growing adoption of personalized medicine supported by genomics and biomarker-based blood analysis
      • 5.1.1.3. Surging expansion of point-of-care testing facilities improving accessibility to immediate diagnostic results
    • 5.1.2. Restraints
      • 5.1.2.1. High production and operational costs linked with advanced blood testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and machine learning in advanced blood testing technologies
      • 5.1.3.2. Investments in research and development to innovate blood testing technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns and potential misuse of sensitive patient information
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Test Type: Rising demand for basic metabolic panels for assessing electrolyte imbalance and renal function
    • 5.2.2. End-User: Growing usage of blood testing technologies in blood banks to ensure safe transfusions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Testing Market, by Products

  • 6.1. Introduction
  • 6.2. Blood Collection
    • 6.2.1. Blood Collection Tubes (BCTs)
    • 6.2.2. Capillary Blood Collection Devices
    • 6.2.3. Lancets
    • 6.2.4. Syringes & Needles
  • 6.3. Blood Testing Instruments
    • 6.3.1. Biochemical Analyzers
    • 6.3.2. Coagulation Analyzers
    • 6.3.3. Hematology Analyzers
    • 6.3.4. Immunoassay Analyzers
  • 6.4. Reagents & Consumables
  • 6.5. Software & Data Management Solutions

7. Blood Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Basic Metabolic Panels
  • 7.3. Complete Blood Count Tests
  • 7.4. Complete Metabolic Panels
  • 7.5. Electrolyte Panels

8. Blood Testing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Arterial Blood Samples
  • 8.3. Capillary Blood Samples
  • 8.4. Plasma/Serum Samples
  • 8.5. Venous Blood Samples

9. Blood Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Allergies
  • 9.3. Autoimmune Diseases
  • 9.4. Cancer/Noncancerous Blood Disorders
  • 9.5. Endocrine System Disorders
  • 9.6. Heart Diseases

10. Blood Testing Market, by End-User

  • 10.1. Introduction
  • 10.2. Blood Banks
  • 10.3. Diagnostic Centers
  • 10.4. Hospital & Clinics
  • 10.5. Pathology Labs

11. Americas Blood Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Tasso and ARUP partner to revolutionize decentralized biomarker testing with at-home blood collection
    • 14.3.2. Curelo launch 10-minute doorstep blood testing service meets evolving consumer expectations
    • 14.3.3. Strand Life Sciences launches CancerSpot to revolutionize early cancer detection with advanced genomic sequencing and a state-of-the-art diagnostics research center
    • 14.3.4. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
    • 14.3.5. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
    • 14.3.6. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc.
  • 4. ARKRAY, Inc.
  • 5. B. Braun Melsungen AG
  • 6. Becton Dickinson & Company
  • 7. Bio-Rad Laboratories Inc.
  • 8. BioMerieux SA
  • 9. Danaher Corporation
  • 10. F. Hoffmann-La Roche AG
  • 11. Johnson & Johnson Services, Inc.
  • 12. Medtronic PLC
  • 13. Merck KGaA
  • 14. Nipro Corporation
  • 15. Nova Biomedical Corporation
  • 16. Ortho Clinical Diagnostics, Inc.
  • 17. Quest Diagnostic
  • 18. Randox Laboratories Ltd.
  • 19. Siemens AG
  • 20. Terumo Corporation
  • 21. Thermo Fisher Scientific, Inc.
  • 22. Trinity Biotech PLC
  • 23. Trividia Health, Inc.
  • 24. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. BLOOD TESTING MARKET MULTI-CURRENCY
  • FIGURE 2. BLOOD TESTING MARKET MULTI-LANGUAGE
  • FIGURE 3. BLOOD TESTING MARKET RESEARCH PROCESS
  • FIGURE 4. BLOOD TESTING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION TUBES (BCTS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY CAPILLARY BLOOD COLLECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY BIOCHEMICAL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY COAGULATION ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD TESTING MARKET SIZE, BY ARTERIAL BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD TESTING MARKET SIZE, BY CAPILLARY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD TESTING MARKET SIZE, BY PLASMA/SERUM SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD TESTING MARKET SIZE, BY VENOUS BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 334. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 335. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2024